VBIO Valion Bio, Inc.: institutional ownership and insider trading
12 funds reported holding $499K of Valion Bio, Inc. in their latest 13F filings; in Q2 2026 funds net bought $69.6K, with 5 new positions and 1 funds selling out; over the last 12 months insiders bought $28.5K and sold $0 on the open market.
VBIO revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$7.10M
- Quarter ended Mar 31, 2026: revenue n/a, net income −$6.20M
- Quarter ended Dec 31, 2025: revenue n/a, net income −$2.85M
- Quarter ended Sep 30, 2025: revenue $146K, net income −$2.60M
Famous investors holding VBIO
- Ken Griffin (Citadel Advisors): $38.5K, 0.0% of the portfolio
Largest institutional holders of VBIO
- LASRY MARC — $294K
- Murchinson Ltd. — $59.8K
- CITADEL ADVISORS LLC — $38.5K
- Sanctuary Advisors, LLC — $31.8K
- Marex Group plc (MRX) — $28.2K
- Virtu Financial LLC — $20.0K
- GEODE CAPITAL MANAGEMENT, LLC — $10.1K
- UBS Group AG (UBS) — $5.77K
- TWO SIGMA SECURITIES, LLC — $5.28K
- HRT FINANCIAL LP — $5.00K
Recent VBIO insider trades
- Apr 15, 2026: Bolton Sheryle bought 10,000 shares ($10.4K)
- Apr 1, 2026: Valauri Christina Rizopoulos bought 19,000 shares ($18.1K)
5%+ owners
- Murchinson Ltd.: 10.0% (Schedule 13G, filed Jul 17, 2026)
- 3i, LP: 9.9% (Schedule 13D/A, filed Aug 27, 2026)
Who owns the most VBIO stock?
The largest institutional holders of Valion Bio, Inc. in the latest 13F filings are LASRY MARC ($294K), Murchinson Ltd. ($59.8K), CITADEL ADVISORS LLC ($38.5K).
Are insiders buying or selling VBIO?
Over the last 12 months insiders bought $28.5K and sold $0 of Valion Bio, Inc. stock on the open market (SEC Form 4).
Which famous investors own VBIO?
Ken Griffin.